4.6 Article

Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM)

Journal

PAIN
Volume 152, Issue 2, Pages 397-402

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1016/j.pain.2010.11.006

Keywords

Prescription drug use disorder; Primary care; Diagnosis

Funding

  1. National Institute of Drug Abuse [K23 DA016665, K24 DA022288]

Ask authors/readers for more resources

The Current Opioid Misuse Measure (COMM), a self-report assessment of past-month aberrant medication-related behaviors, has been validated in specialty pain management patients. The performance characteristics of the COMM were evaluated in primary care (PC) patients with chronic pain. It was hypothesized that the COMM could identify patients with prescription drug use disorder (PDD). English-speaking adults awaiting PC visits at an urban, safety-net hospital, who had chronic pain and had received any opioid analgesic prescription in the past year, were administered the COMM. The Composite International Diagnostic Interview served as the gold standard, using DSM-IV criteria for PDD and other substance use disorders (SUDs). A receiver operating characteristic (ROC) curve demonstrated the COMM's diagnostic test characteristics. Of the 238 participants, 27 (11%) met DSM-IV PDD criteria, whereas 17 (7%) had other SUDs, and 194 (82%) had no disorder. The mean COMM score was higher in those with PDD than among all others (ie, those with other SUDs or no disorder, mean 20.4 [ SD 10.8] vs 8.4 [SD 7.5], P < .0001). A COMM score of >= 13 had a sensitivity of 77% and a specificity of 77% for identifying patients with PDD. The area under the ROC curve was 0.84. For chronic pain patients prescribed opioids, the development of PDD is an undesirable complication. Among PC patients with chronic pain-prescribed prescription opioids, the COMM is a promising tool for identifying those with PDD. (c) 2010 International Association for the Study of Pain. Published by Elsevier B. V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Substance Abuse

Patients at a drug detoxification center share perspectives on how to increase hepatitis C treatment uptake: A qualitative study

Sabrina A. Assoumou, Carlos R. Sian, Christina M. Gebel, Benjamin P. Linas, Jeffrey H. Samet, Judith A. Bernstein

Summary: The study found that active substance use was a major barrier to HCV treatment uptake, and patients suggested improvements such as high-intensity wraparound care, same-day/walk-in options, low-barrier access to substance use treatment, and attention to immediate needs.

DRUG AND ALCOHOL DEPENDENCE (2021)

Review Anesthesiology

Framework for opioid stigma in cancer pain

Hailey W. Bulls, Edward Chu, Burel R. Goodin, Jane M. Liebschutz, Antoinette Wozniak, Yael Schenker, Jessica S. Merlin

Summary: This article discusses the issue of opioid stigma faced by cancer patients using prescription opioids for pain management. It proposes the Opioid Stigma Framework (OSF) to understand and improve opioid stigma in this population. The framework covers factors contributing to opioid stigma, intersections of multiple stigmatized identities, manifestations of stigma, immediate and long-term impacts, and provides guidance for future research.
Article Clinical Neurology

Nonmedical Use of Xtampza® ER and Other Oxycodone Medications in Adults Evaluated for Substance Abuse Treatment: Real-World Data from the Addiction Severity Index-Multimedia Version (ASI-MV®)

Jody L. Green, Rebekkah S. Robbins, Taryn Dailey-Govoni, Stephen F. Butler

Summary: The study evaluated real-world data on the past 30-day nonmedical use (NMU) and routes of administration of Xtampza ER and comparator oxycodone medications in the US using data from the Addiction Severity Index. Xtampza ER had significantly lower rates of NMU than other oxycodone ER and oxycodone IR, as well as significantly lower rates of non-oral NMU than oxycodone IR.

JOURNAL OF PAIN RESEARCH (2021)

Review Substance Abuse

Effects of brief substance use interventions delivered in general medical settings: a systematic review and meta-analysis

Emily E. Tanner-Smith, Nicholas J. Parr, Maria Schweer-Collins, Richard Saitz

Summary: Brief substance use interventions delivered in general medical settings may lead to small beneficial reductions in alcohol consumption, but evidence regarding drug-targeted interventions is limited.

ADDICTION (2022)

Editorial Material Medicine, General & Internal

In the Clinic Opioid Use Disorder

Jessica L. Taylor, Jeffrey H. Samet

ANNALS OF INTERNAL MEDICINE (2022)

Article Substance Abuse

Impact of the international collaborative addiction medicine research fellowship on physicians' future engagement in addiction research

Jan Klimas, Huiru Dong, Michee-Ana Hamilton, Walter Cullen, Jeffrey H. Samet, Evan Wood, Nadia Fairbairn

Summary: The international one-year intensive research training program for addiction medicine physicians had a significant impact on subsequent research involvement and productivity. Physicians who participated in the program had higher publication rates compared to the control group, indicating successful training in recruiting addiction medicine physicians for addiction research.

SUBSTANCE ABUSE (2022)

Review Substance Abuse

Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysis

Anees Bahji, Paxton Bach, Marlon Danilewitz, David Crockford, Nady El-Guebaly, Daniel J. Devoe, Richard Saitz

Summary: This study evaluated the comparative performance of pharmacotherapies for alcohol withdrawal and found that some medications, especially benzodiazepines, appear to be safe and effective in reducing certain measures of alcohol withdrawal. However, methodological issues and a high risk of bias prevent a consistent estimate of their comparative performance.

ADDICTION (2022)

Article Substance Abuse

Alcohol and falls among people with HIV infection: A view from Russia and the United States

Theresa W. Kim, Timothy C. Heeren, Jeffrey H. Samet, Nicolas Bertholet, Christine Lloyd-Travaglini, Michael R. Winter, Kara M. Magane, Natalia Gnatienko, Kendall Bryant, Lindsey J. Rateau, Winnie R. Muyindike, Judith A. Hahn, Elena Blokhina, Richard Saitz

Summary: There is an association between alcohol use and falls, with severity of alcohol use disorder symptoms and heavy alcohol use being potential targets for fall prevention interventions.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Article Substance Abuse

Cannabis and cocaine use, drinking outcomes, and quality of life in general hospital inpatients with alcohol use disorder

Esperanza Romero-Rodriguez, Clara A. Chen, Kimberly A. Dukes, Kaitlin Hartlage, Tibor P. Palfai, Kara M. Magane, Jeffrey H. Samet, Richard Saitz

Summary: This study found no significant associations between cannabis and cocaine use, heavy drinking, or quality of life among hospital inpatients with alcohol use disorder (AUD). These findings raise questions about the impact of drug use on AUD and the generalizability of the results to individuals with milder AUD and prospective studies.

SUBSTANCE ABUSE (2022)

Article Oncology

Manifestations of Opioid Stigma in Patients With Advanced Cancer: Perspectives From Patients and Their Support Providers

Hailey W. Bulls, Megan Hamm, Rachel Wasilko, Flor de Abril Cameron, Shane Belin, Burel R. Goodin, Jane M. Liebschutz, Antoinette Wozniak, Lindsay M. Sabik, Jessica S. Merlin, Yael Schenker

Summary: This qualitative study explores the manifestations of opioid stigma in patients with advanced cancer, identifying three primary ways in which it occurs: direct experiences of stigma and discrimination in healthcare settings, concerns about future stigma affecting patient care, and opioid-restricting attitudes and behaviors reflecting internalized stigma and fear of addiction.

JCO ONCOLOGY PRACTICE (2022)

Article Medicine, General & Internal

Evaluation of a student clinical research education program in addiction medicine

Jules Canfield, Ve Truong, Agata Bereznicka, Carly Bridden, Jane Liebschutz, Daniel P. Alford, Richard Saitz, Jeffrey H. Samet, Alexander Y. Walley, Karsten Lunze

Summary: This study evaluated a student clinical addiction research program by analyzing its components, evaluation survey data, and scientific outputs. The program successfully introduced students to addiction medicine and research, with high peer-reviewed publication productivity. However, it needs to improve equity by increasing the recruitment of trainees from disadvantaged groups and engaging underrepresented faculty.

ANNALS OF MEDICINE (2023)

Article Substance Abuse

Association of sex work and social-structural factors with non-fatal overdose among women who use drugs in Vancouver, Canada

Miriam T. H. Harris, Shira Goldenberg, Zishan Cui, Nadia Fairbairn, M-J S. Milloy, Kanna Hayashi, Jeffrey H. Samet, Alexander Y. Walley, Seonaid Nolan

Summary: Women who use drugs and engage in sex work have a higher risk of overdose, however, this risk is driven by social-structural factors such as policing and gendered violence rather than sex work itself.

INTERNATIONAL JOURNAL OF DRUG POLICY (2023)

Article Substance Abuse

Impact of alcohol use disorder severity on human immunodeficiency virus (HIV) viral suppression and CD4 count in three international cohorts of people with HIV

Nicolas Bertholet, Richard Saitz, Judith A. Hahn, Timothy C. Heeren, Nneka I. Emenyonu, Matthew Freiberg, Michael R. Winter, Theresa W. Kim, Kara Magane, Christine Lloyd-Travaglini, Robin Fatch, Kendall Bryant, Leah S. Forman, Lindsey Rateau, Elena Blokhina, Winnie R. Muyindike, Natalia Gnatienko, Jeffrey H. Samet

Summary: This study assessed the association between alcohol use disorder (AUD) severity and HIV viral suppression and CD4 count. The results showed no association between AUD severity and HIV viral suppression or CD4 count in three cohorts.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Substance Abuse

Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods

Jane M. Liebschutz, Geetha A. Subramaniam, Rebecca Stone, Noa Appleton, Lillian Gelberg, Travis I. Lovejoy, Amanda M. Bunting, Charles M. Cleland, Karen E. Lasser, Donna Beers, Catherine Abrams, Jennifer Mccormack, Gail E. Potter, Ashley Case, Leslie Revoredo, Eve M. Jelstrom, Margaret M. Kline, Li-Tzy Wu, Jennifer Mcneely

Summary: The STOP trial aims to study the efficacy of a collaborative care intervention to reduce risky opioid use and prevent progression to moderate or severe OUD in adult primary care patients.

ADDICTION SCIENCE & CLINICAL PRACTICE (2023)

Article Health Care Sciences & Services

Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study

Suzanne K. Vosburg, Taryn Dailey-Govoni, Jared Beaumont, Stephen F. Butler, Jody L. Green

Summary: Web-based surveys successfully recruited individuals who reported nonmedical use of tapentadol, providing background information and individual experiences. The study found that tapentadol was primarily used for pain relief and to produce psychotropic effects, but did not receive a robust pattern of endorsement for nonmedical use.

JMIR FORMATIVE RESEARCH (2022)

No Data Available